Cathay Capital
VC Fund
Paris, France
Cathay Capital is a VC fund in Paris focused on Health Care and Manufacturing. Cathay Capital operates as a global investment firm focused on private equity and venture capital. The company finances growth initiatives for small and midsize enterprises, with activity across North America, Europe, and Asia. It invests in sectors including healthcare, consumer goods, financial services, and software. Cathay Capital also manages venture capital funds that explore areas such as artificial intelligence in industries like energy, fintech, and mobility. The firm supports portfolio companies in cross-border business development and operational growth.
- Total investments:
- 166
- Last investment:
- Lead investor:
- 50%
- Fund size:
- $537M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Cathay Capital invests in
Stages Cathay Capital invests in
Countries Cathay Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $15M–$100M
- Series B
- $14M–$110M
- Venture - Series Unknown
- $4.1M–$43M
Investment Focus
Industry
- Health Care 24 (14%)
- Manufacturing 20 (12%)
- Biotechnology 15 (9%)
- Medical 14 (8%)
- Artificial Intelligence 12 (7%)
Stage
- Series B 30 (18%)
- Venture - Series Unknown 25 (15%)
- Series A 22 (13%)
- Private Equity 21 (13%)
- Seed 16 (10%)
Country
- China 91 (55%)
- France 24 (14%)
- United States 10 (6%)
- Germany 3 (2%)
- Spain 2 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Matthieu van der Elst
Chief Impact Officer
|
Chief Impact Officer | Total investments: 1 | Find email | |
Mingpo Cai
Founder & President
|
Founder & President | Total investments: 24 | Find email | |
Stephan Torra
Partner
|
Partner | Total investments: 1 | Find email | |
Stephen Oesterle
Venture Partner
|
Venture Partner | Total investments: 3 | Find email | |
Zhao Jing
Managing Partner
|
Managing Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector. | Venture - Series Unknown / Sep 28, 2026 | ||
| D-Robotics is a provider of robotic computing solutions. We're committed to delivering paradigm-shifting products that drive efficiency, simplify development and accelerate innovation. | $400M / Series C / Sep 17, 2026 | ||
|
Strong Fields
|
Strong Field is a new materials enterprise focusing on the research and development of engineering application technology of high-temperature superconducting magnets and the sales of related experimental instruments . | Angel / Sep 16, 2026 | |
| QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases. | $44.7M / Series C / Sep 14, 2026 | ||
| Zixun engages in the research and development of cross-border e-commerce digital asset security management platforms. With the purple bird browser as the core, it closely follows the needs of cross-border e-commerce users. The core technologies of big data, cloud computing, and artificial intelligence have expanded into a series of products such asrpa automation, purple bird guard, purple bird data cube, purple bird operation staff, etc., to build a cross-border e-commerce service ecosystem of Zixun, and provide global sellers with more in-depth Digital asset security custody services and data operation guidance to help Chinese manufacturing go overseas.The company was founded in 2015 and is based in Fuzhou City, China. | Private Equity / Sep 10, 2026 | ||
|
Stellar Power
|
Stellar Power is an aerospace energy technology company focused on the research and development of advanced space energy technologies, specializing in innovative hard-tech solutions for energy generation, storage, and transmission to support the future of aerospace and space exploration industries. | Seed / Aug 31, 2026 | |
| ENN develops technologies and conducts research focused on sustainable energy solutions. The company works on proton-boron fusion, compact fusion systems, and other advanced energy generation approaches. Its services include designing experimental fusion reactors, modeling plasma behavior, and developing computational tools for energy simulations.ENN also engages in partnerships with universities, research institutes, and industry organizations to advance innovation in energy science. The company supports efforts to create scalable, low-carbon energy technologies and to explore applications in electricity generation and related scientific research. | Seed / Jul 10, 2026 | ||
|
ENN Fusion
|
ENN Fusion is a commercialization company that specializes in research and commercial application of spherical cyclic hydrogen-boron fusion technology. | Seed / Jul 10, 2026 | |
| Snapmaker is dedicated to providing an integrated platform empowering everyone to create things with ease that just wasn’t there before. | $147.1M / Series C / Jul 08, 2026 | ||
| Ascendia Autism Care is a clinician-led platform behind trusted autism services. The company believes that the best autism care is delivered by organizations deeply embedded in their communities. | Seed / Jun 29, 2026 | ||
| See all 166 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Cathay Capital invest in?
Cathay Capital invests primarily in Health Care, Manufacturing and Biotechnology startups, most often at Series B and Venture - Series Unknown stage. Most of the 166 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Cathay Capital invest in?
Cathay Capital typically joins rounds of $15M–$100M at Series A, $14M–$110M at Series B and $4.1M–$43M at Venture - Series Unknown. These are whole funding-round sizes, not Cathay Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Cathay Capital took part in.
How do I contact Cathay Capital?
Public channels for Cathay Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cathay Capital?
The team at Cathay Capital includes Matthieu van der Elst (Chief Impact Officer), Mingpo Cai (Founder & President) and Stephan Torra (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
